HIV 1 News and Research

RSS

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

Low blood phosphorus levels are associated with high death rates in the initial weeks of antiretroviral therapy (ART) in AIDS patients in sub-Saharan Africa, according to new research conducted by University of Alabama at Birmingham researchers at the UAB-affiliated Centre for Infectious Disease Research in Zambia.

19 May 2010

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

"Gender-based violence is a world-wide pandemic and directly affects the spread of HIV/AIDS. Fear of violence limits the ability of women and girls to choose their partners; to find out about a partner's HIV status or disclose their own; and to get medical or counseling services," according to a U.S. government editorial in VOA News.

19 May 2010

Newly-discovered watchmen DCs instruct T cells to attack and destroy cancer cells

Cancer Research UK scientists have discovered sophisticated 'watchman' cells in humans that can instruct the immune system to destroy foreign invaders like viruses and cancer cells, according to research published in The Journal of Experimental Medicine.

19 May 2010

New test to detect HBV receives regulatory approval for use in the European Union

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, enabling doctors to take immediate action on health decisions.

19 May 2010

GHESKIO awarded prestigious 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.

19 May 2010

Where are Australia’s missing hepatitis C cases?

Around 90% of those infected have not received treatment, despite the potential for cure, a report to coincide with National Hepatitis Week shows

18 May 2010

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.

18 May 2010

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Immunetics, Inc. has been selected to receive a $2.8 million contract as part of the National Heart, Lung, and Blood Institute's Retrovirus Epidemiology Donor Study-II project, a long term epidemiologic study of blood safety involving HIV and other infectious and non-infectious complications of blood transfusion.

18 May 2010

Thai AIDS vaccine trial: Risk of HIV infection can be reduced with a vaccine

For more than a decade, researchers and advocates have marked HIV Vaccine Awareness Day with varying degrees of hope, cynicism and despair. This year, in large part because of the results of the Thai Prime-Boost vaccine study, there is greater cause for hope than ever before and a renewed sense of urgency to transform this hope into a reality.

18 May 2010

GHESKIO honored with 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of ground-breaking clinical service, research, and training to treat effectively and prevent the spread of the HIV/AIDS and other related illnesses, the Global Health Council announced today.

18 May 2010

Scientists discover prothymosin-alpha protein to control HIV and other infections

Scientists at Duke University Medical School and Mount Sinai School of Medicine have found a new role for a host protein that provides further insight into how CD8+ T cells work to control HIV and other infections. Study authors say the finding may yield new strategies for prevention or treatment.

18 May 2010

Investigators pursue N.Y. leads on hospital corruption; Crack down in Fla. fraud probe

A New York hospital system has become entwined in a corruption scandal that sent a state lawmaker to prison for six years, The Wall Street Journal reports. "Former trustees of one of the hospitals operated by MediSys Health Network, speaking for the first time, say MediSys executives kept board members in the dark about business dealings between company management and Anthony Seminerio, the former lawmaker who pleaded guilty to a federal corruption charge."

18 May 2010

Report examines access to HIV prevention, care for MSM in Asia Pacific

As "HIV prevalence among gay and bisexual men has hit alarming levels in Asia," an estimated 90 percent of men who have sex with men in the Asia Pacific region lack access to HIV prevention and care, according to a report released Monday by the U.N. Development Programme, Asia Pacific Coalition on Male Sexual Health and the University of Hong Kong's Center for Comparative and Public Law, Reuters reports.

18 May 2010

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

18 May 2010

Five-day World Health Assembly meeting kicks off in Geneva

The annual meeting of the World Health Assembly (WHA) convened on Monday in Geneva, Switzerland, Deutsche Presse-Agentur/Monsters and Critics.com reports. According to the news service, influenza vaccines, the fight against tuberculosis, intellectual property and reducing counterfeit drugs will be discussed (4/17).

18 May 2010

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.

18 May 2010

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Argos Therapeutics today announced the presentation of data from the Phase 2a trial of AGS-004, demonstrating that the personalized immunotherapy has a positive impact on the genetic diversity of residual HIV virus, and also results in substantially increased time to viral rebound in HIV patients treated with AGS-004 following antiretroviral therapy (ART) interruption.

17 May 2010

Inovio Biomedical changes corporate name to Inovio Pharmaceuticals

Inovio Biomedical Corporation, a leader in the development of new preventive and therapeutic vaccines against cancers and infectious diseases, announced today that it has changed its corporate name to Inovio Pharmaceuticals, Inc. by filing a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware on May 14, 2010. Inovio's trading symbol remains the same.

17 May 2010

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

NanoViricides, Inc., announced that it has signed a Research Agreement with the University of California, San Francisco for testing of its anti-HIV drug candidates. Cheryl Stoddart, PhD, Assistant Professor in the UCSF Division of Experimental Medicine, will be the Principal Investigator.

17 May 2010

Polypill to be tested in new heart disease trial

17 May 2010

HIV 1 News and Research

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

Newly-discovered watchmen DCs instruct T cells to attack and destroy cancer cells

New test to detect HBV receives regulatory approval for use in the European Union

GHESKIO awarded prestigious 2010 Gates Award for Global Health

Where are Australia’s missing hepatitis C cases?

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Thai AIDS vaccine trial: Risk of HIV infection can be reduced with a vaccine

GHESKIO honored with 2010 Gates Award for Global Health

Scientists discover prothymosin-alpha protein to control HIV and other infections

Investigators pursue N.Y. leads on hospital corruption; Crack down in Fla. fraud probe

Report examines access to HIV prevention, care for MSM in Asia Pacific

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Five-day World Health Assembly meeting kicks off in Geneva

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Inovio Biomedical changes corporate name to Inovio Pharmaceuticals

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

Polypill to be tested in new heart disease trial

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News